94 samples did not include heart disease and high BP medicine in Himachal, see here List - Drug Alert 94 Medicine Failed Quality Tests, including Heart and BP medicine

Updated: Sun, 21 Sep 2025 12:29 am (IST) In the investigation of CDSCO and state clothing regulators in Himachal Pradesh, samples of 94 medicines, including medicines used in heart disease, failed, three of which were false. In August, drug warning, 38 medicines made in 31 pharmaceutical industries in Himachal, failed. These medicines include medicines used in the treatment of acid fever and high BP. 94 samples of medicine failed. (Photo Jagran) Jagran correspondent, Solan. A total of 94 samples from 94 medicines, including heart disease, failed high BP medicine in the investigation of the Central Drug Standards Control Organization (CDSCO) and state regulators. Three medicines also came out in the investigation. Remove ad just read the news. In August, drug warning, 38 medicines produced in 31 pharmaceutical industries in Himachal, did not meet the quality scale. These include medicines in the treatment of diseases such as acidity, fever, ulcers, heart disease, inflammation, arthritis, stomach worms and high BP. Samples of 56 medicines made in industries in other countries also failed. The failed samples of these medicines include omega-3 fatty acid capsules manufactured in Baddi, Himachal. Daxamethason -sodium phosphate injection produced in arthritis in the Syrmaur district is poor. The medicine of urinary tract infection that failed in the Nalagarh sahib, Amicacin sulfate injection and pain reliever, failed in the investigation into trauma hydrochloride capsules. At the same time, samples of medicines given in high BP, along with medicines made in Uttarakhand, chest irritation, calcium and vitamin D, have also failed. The heart disease produced in Punjab and the drug used in migraine, and the sample of injections made during childbirth in Indore, also failed. In addition, five symptoms of five syrup built in Baddi also failed in the investigation. Industries whose samples of medicine failed were given notice and instructed to remove the group associated with the market. The units whose names are constantly in the monthly list will be investigated and acted. Illegal manufacturers prepare false medicines from a well -known brand and take it in the market, especially heart disease and blood pressure. It is monitored by the center and state regulatory. – Manish Kapoor, drug controller of the state (Himachal).